Advertisement

Topics

MyoKardia, Inc. Company Profile

14:12 EST 13th December 2018 | BioPortfolio

MyoKardia is dedicated to revolutionizing the treatment of genetic cardiovascular disease. The company’s proprietary platform combines recent breakthroughs in muscle biology with leading-edge cardiovascular disease genetics. This personalized, genetically targeted approach focuses on the underlying cause of disease and has the potential to drastically improve the treatment of cardiomyopathies, and ultimately a broader spectrum of cardiovascular disease, including heart failure. Founded by world leaders in muscle biology and cardiovascular disease genetics, MyoKardia was launched in 2012 with funding from leading life sciences investor, Third Rock Ventures. For more information, please visit www.myokardia.com.


News Articles [11 Associated News Articles listed on BioPortfolio]

MyoKardia’s myosin mechanism deconvolution

Finding that mavacamten has two complementary activities, MyoKardia has opened a slate of preclinical programs to tap the separate mechanisms for different genetic diseases.

MyoKardia to Present at the BMO 2018 Prescriptions for Success Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Dec. 05, 2018 (GLOBE NEWSWIRE) — MyoKardia, Inc. (Nasdaq: MYOK), a clinical-stage biopharmaceutical company pioneering precision medicine for the treatment of cardio...

MyoKardia Reports Positive Data from Phase 1b Single-Ascending Dose Clinical Trial of MYK-491

MyoKardia (Nasdaq:MYOK), a clinical-stage biopharmaceutical company pioneering precision medicine for the treatment of cardiovascular diseases, today announced topline results from the Phase 1b single...

MS $MYOK Tone on MyoKardia more neutral, although some are skeptical made up ~10% of conversations.spoke with some clients who are skeptical of MyoKardia&question whether their targeted therapy approach will succeed given the difficulty in treating these

MS $MYOK Tone on MyoKardia more neutral, although some are skeptical made up ~10% of conversations.spoke with some clients who are skeptical of MyoKardia&question whether their targeted therapy a...

MyoKardia's heart failure candidate shows proof of mechanism in Phase Ia

MS $EXEL received the most feedback and pushback on our counter- consensus Exelixis call. Other names frequently asked about include Neurocrine, MyoKardia, and Alder.

MS $EXEL received the most feedback and pushback on our counter- consensus Exelixis call. Other names frequently asked about include Neurocrine, MyoKardia, and Alder.

$MYOK Doses First Patient in MAVA Long-Term Extension Study of Mavacamten for Hypertrophic Cardiomyopathy https://finance.yahoo.com/news/myokardia-doses-first-patient-mava-203000603.html …

$MYOK Doses First Patient in MAVA Long-Term Extension Study of Mavacamten for Hypertrophic Cardiomyopathy https://finance.yahoo.com/news/myokardia-doses-first-patient-mava-203000603.html &helli...

MyoKardia Inc MYOK Financial and Strategic SWOT Analysis Review [Report Updated: 12092018] Prices from USD $125

MyoKardia Inc MYOK Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

MyoKardia, Inc.

MyoKardia is dedicated to revolutionizing the treatment of genetic cardiovascular disease. The company’s proprietary platform combines recent breakthroughs in muscle biology ...

More Information about "MyoKardia, Inc." on BioPortfolio

We have published hundreds of MyoKardia, Inc. news stories on BioPortfolio along with dozens of MyoKardia, Inc. Clinical Trials and PubMed Articles about MyoKardia, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MyoKardia, Inc. Companies in our database. You can also find out about relevant MyoKardia, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...


Corporate Database Quicklinks



Searches Linking to this Company Record